$SLS·4

Galena Biopharma, Inc. · Feb 7, 4:58 PM ET

Galena Biopharma, Inc. 4

4 · Galena Biopharma, Inc. · Filed Feb 7, 2017

Insider Transaction Report

Form 4
Period: 2017-02-06
Knapp Thomas J
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2017-02-06+10,00010,000 total
    Exercise: $1.41Exp: 2027-02-06Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]Granted pursuant to the Issuer's 2016 Incentive Plan.
  • [F2]This stock option will vest in equal, monthly installments over 8 months beginning May 1, 2017 through December 31, 2017, so long as the Reporting Person remains in the company's continuous employ through the vesting period.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT